Cecil D. Haney
Known title: DirectorCIK: 0001769664
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Tenet Healthcare Raises 2026 Outlook, Analysts Lift Targets. Tenet Healthcare recently raised its 2026 financial outlook, prompting analysts like Guggenheim to increase price targets to $307. This positive guidance has driven the stock higher, with the average analyst target now sitting at $285.32. While the company is trading near its 52-week high, questions remain about whether this recent strength is fully reflected in the current valuation.
Transaction History
| GD | ▲ Buy | Grant | 10 | $4K | 9/16/2026 | View on chart |
| THC | ▼ Sell | Gift | 150 | $0 | 8/28/2026 | View on chart |
| THC | ▼ Sell | Open Market | 1,300 | $361K | 8/24/2026 | View on chart |
| GD | ▲ Buy | Grant | 10 | $4K | 6/16/2026 | View on chart |
| THC | ▲ Buy | Option Exercise | 1,333 | — | 5/22/2026 | View on chart |
| THC | ▼ Sell | Other | 493 | $86K | 5/22/2026 | View on chart |
| GD | ▲ Buy | Grant | 10 | $4K | 3/17/2026 | View on chart |
| GD | ▼ Sell | Tax Withholding | 83 | $30K | 3/9/2026 | View on chart |
| GD | ▲ Buy | Grant | 270 | $0 | 3/4/2026 | View on chart |
| GD | ▲ Buy | Grant | 9 | $3K | 12/16/2025 | View on chart |
| GD | ▲ Buy | Grant | 9 | $3K | 9/16/2025 | View on chart |
| GD | ▲ Buy | Grant | 11 | $3K | 6/17/2025 | View on chart |
| THC | ▲ Buy | Option Exercise | 1,551 | — | 5/23/2025 | View on chart |
| THC | ▼ Sell | Other | 573 | $92K | 5/23/2025 | View on chart |
| GD | ▲ Buy | Grant | 11 | $3K | 3/18/2025 | View on chart |
| GD | ▲ Buy | Grant | 330 | $0 | 3/5/2025 | View on chart |
| THC | ▼ Sell | Open Market | 2,500 | $311K | 3/4/2025 | View on chart |
| GD | ▼ Sell | Tax Withholding | 81 | $21K | 3/3/2025 | View on chart |
| GD | ▲ Buy | Grant | 11 | $3K | 12/17/2024 | View on chart |
| GD | ▲ Buy | Grant | 10 | $3K | 9/17/2024 | View on chart |
| GD | ▲ Buy | Grant | 10 | $3K | 6/18/2024 | View on chart |
| GD | ▲ Buy | Grant | 11 | $3K | 3/18/2024 | View on chart |
| GD | ▲ Buy | Grant | 310 | $0 | 3/6/2024 | View on chart |
| GD | ▼ Sell | Tax Withholding | 105 | $29K | 3/4/2024 | View on chart |
| GD | ▲ Buy | Grant | 12 | $3K | 12/18/2023 | View on chart |
| GD | ▲ Buy | Grant | 14 | $3K | 9/18/2023 | View on chart |
| GD | ▲ Buy | Grant | 14 | $3K | 6/16/2023 | View on chart |
| THC | ▲ Buy | Grant | 2,846 | $0 | 5/26/2023 | View on chart |
| GD | ▲ Buy | Grant | 14 | $3K | 3/16/2023 | View on chart |
| GD | ▲ Buy | Grant | 375 | $0 | 3/8/2023 | View on chart |
| GD | ▼ Sell | Tax Withholding | 107 | $25K | 3/6/2023 | View on chart |
| GD | ▲ Buy | Grant | 25 | $6K | 12/16/2022 | View on chart |
| GD | ▲ Buy | Grant | 27 | $6K | 9/16/2022 | View on chart |
| GD | ▲ Buy | Grant | 28 | $6K | 6/16/2022 | View on chart |
| THC | ▲ Buy | Grant | 3,836 | $0 | 5/9/2022 | View on chart |
| GD | ▲ Buy | Grant | 26 | $6K | 3/16/2022 | View on chart |
| GD | ▼ Sell | Tax Withholding | 98 | $25K | 3/7/2022 | View on chart |
| GD | ▲ Buy | Grant | 365 | $0 | 3/2/2022 | View on chart |
| GD | ▲ Buy | Grant | 23 | $5K | 12/16/2021 | View on chart |
| GD | ▲ Buy | Grant | 24 | $5K | 9/16/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
RBC Lowers General Dynamics Price Target Amid Defense Sector Review
RBC Capital cut its price target for General Dynamics to $360 while maintaining a Sector Perform rating. This action occurs as broader defense stocks face pressure, with recent reports questioning if strong profitability can overcome weak momentum in the sector. The stock is currently trading near significant support levels, reflecting a cautious market stance on the company's near-term outlook.
RBC Lowers General Dynamics Price Target Amid Defense Sector Review. RBC Capital cut its price target for General Dynamics to $360 while maintaining a Sector Perform rating. This action occurs as broader defense stocks face pressure, with recent reports questioning if strong profitability can overcome weak momentum in the sector. The stock is currently trading near significant support levels, reflecting a cautious market stance on the company's near-term outlook.